Altered spectrum of target genes in the TGFβ and Wnt/CTNNB1 cell signaling pathways, and increased LEF1 and SOX9 expression tending toward biliary differentiation (similar to ICC) (52). The gene discussed is CTNNB1; the disease is intrahepatic cholangiocarcinoma.